1. Home
  2. FOXF vs VERA Comparison

FOXF vs VERA Comparison

Compare FOXF & VERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FOXF
  • VERA
  • Stock Information
  • Founded
  • FOXF 2007
  • VERA 2016
  • Country
  • FOXF United States
  • VERA United States
  • Employees
  • FOXF N/A
  • VERA N/A
  • Industry
  • FOXF Motor Vehicles
  • VERA Biotechnology: Pharmaceutical Preparations
  • Sector
  • FOXF Consumer Discretionary
  • VERA Health Care
  • Exchange
  • FOXF Nasdaq
  • VERA Nasdaq
  • Market Cap
  • FOXF N/A
  • VERA 2.0B
  • IPO Year
  • FOXF N/A
  • VERA 2021
  • Fundamental
  • Price
  • FOXF $28.98
  • VERA $23.82
  • Analyst Decision
  • FOXF Buy
  • VERA Buy
  • Analyst Count
  • FOXF 7
  • VERA 8
  • Target Price
  • FOXF $36.43
  • VERA $64.63
  • AVG Volume (30 Days)
  • FOXF 502.6K
  • VERA 1.4M
  • Earning Date
  • FOXF 07-31-2025
  • VERA 08-07-2025
  • Dividend Yield
  • FOXF N/A
  • VERA N/A
  • EPS Growth
  • FOXF N/A
  • VERA N/A
  • EPS
  • FOXF N/A
  • VERA N/A
  • Revenue
  • FOXF $1,415,479,000.00
  • VERA N/A
  • Revenue This Year
  • FOXF $5.17
  • VERA N/A
  • Revenue Next Year
  • FOXF $6.34
  • VERA N/A
  • P/E Ratio
  • FOXF N/A
  • VERA N/A
  • Revenue Growth
  • FOXF 1.26
  • VERA N/A
  • 52 Week Low
  • FOXF $17.95
  • VERA $18.53
  • 52 Week High
  • FOXF $54.86
  • VERA $51.61
  • Technical
  • Relative Strength Index (RSI)
  • FOXF 68.06
  • VERA 52.93
  • Support Level
  • FOXF $27.55
  • VERA $22.57
  • Resistance Level
  • FOXF $29.56
  • VERA $24.58
  • Average True Range (ATR)
  • FOXF 1.18
  • VERA 1.22
  • MACD
  • FOXF 0.24
  • VERA 0.14
  • Stochastic Oscillator
  • FOXF 89.69
  • VERA 69.80

About VERA Vera Therapeutics Inc.

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.

Share on Social Networks: